Kinfo
MaxCyte, Inc. logo

MaxCyte, Inc.

MXCTNASDAQHealthcare·US · USD
$1.08
+0.01 (+0.93%)
Prices as of October 5, 2026 · market closed

Price

Key statistics

Valuation
Market cap111.46M USD
Enterprise value21.99M USD
Trailing P/E-2.60
Forward P/E-4.46
PEG ratio0.08
Price / sales3.64
Price / book0.73
Profitability
Gross margin76.96%
Operating margin-140.72%
Profit margin-114.77%
Return on assets-10.64%
Return on equity-20.39%
Income (TTM)
Revenue31.05M USD
Gross profit24.60M USD
EBITDA-30.29M USD
Net income-35.64M USD
Diluted EPS-$0.34
Rev. growth (YoY)-14.50%
Balance sheet
Total cash105.69M USD
Total debt17.25M USD
Debt / equity10.87
Current ratio12.26
Book value / share$1.50
Cash flow (TTM)
Operating cash flow-22.98M USD
Levered free cash flow-13.14M USD
Shares & price
Shares outstanding106.13M
Float93.72M
Held by institutions61.98%
Beta1.49
50-day MA$1.21
200-day MA$1.08
52-week high$1.87
52-week low$0.64
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-12-0.09-0.08+11.11%2026-04-10-0.16-0.14+12.50%2026-03-24-0.08-0.06+25.00%2026-02-041.321.35+2.27%
About MaxCyte, Inc.

MaxCyte, Inc. is a life sciences tools company focused on cell engineering for cell and gene therapy development. MaxCyte designs and commercializes non-viral flow electroporation systems, proprietary processing assemblies, and consumables that help biotechnology and pharmaceutical companies introduce biological cargo into cells with precision and consistency. Its platform is used across drug discovery, translational research, and biomanufacturing, supporting applications in gene editing, immuno-oncology, and other advanced cell-based medicines. The company also offers licensing arrangements tied to partner programs, making its technology part of broader therapeutic development workflows. Headquartered in Rockville, Maryland, MaxCyte serves a global customer base involved in next-generation cell therapeutics and related research.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Maher Masoud
Employees
114
Headquarters
Rockville, MD, United States

Frequently asked questions about MaxCyte, Inc.